nameofissuer,titleofclass,cusip,value,sshprnamt,sshprnamttype,investmentdiscretion,sole,shared,none,cik,reportcalendarorquarter,submissiontype,isamendment,filer,signaturedate,putcall,ticker
ABBOTT LABORATORIES,Equity,002824100,6857,75000,SH,SOLE,75000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,ABT
AMYRIS INC,Equity,03236M200,5693,1333333,SH,SOLE,1333333,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
ATRICURE INC,Equity,04963C209,10114,225000,SH,SOLE,225000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,ATRC
BIO-RAD LABORATORIES-A,Equity,090572207,13545,30000,SH,SOLE,30000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
QUEST DIAGNOSTICS INC,Equity,74834L100,31339,275000,SH,SOLE,275000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,DGX
GLD US 01/15/21 C150,Listed Option,78463V907,8208,4000,SH,SOLE,4000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,Call,
GW PHARMACEUTICALS -ADR,Depository Receipt,36197T103,11045,90000,SH,SOLE,90000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,GWPH
HOLOGIC INC,Equity,436440101,18525,325000,SH,SOLE,325000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,HOLX
ICU MEDICAL INC,Equity,44930G107,14376,78000,SH,SOLE,78000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,ICUI
IVERIC BIO INC,Equity,46583P102,5100,1000000,SH,SOLE,1000000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,ISEE
LABORATORY CRP OF AMER HLDGS,Equity,50540R409,9136,55000,SH,SOLE,55000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,LH
LANTHEUS HOLDINGS INC,Equity,516544103,13585,950000,SH,SOLE,950000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,LNTH
ALLSCRIPTS HEALTHCARE SOLUTI,Equity,01988P108,10832,1600000,SH,SOLE,1600000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
MEDTRONIC PLC,Equity,585055106,13755,150000,SH,SOLE,150000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
MISONIX INC,Equity,604871103,4370,322041,SH,SOLE,322041,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,MSON
MYLAN NV,Equity,628530107,6432,400000,SH,SOLE,400000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
NATERA INC,Equity,632307104,2992,60000,SH,SOLE,60000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,NTRA
NUANCE COMMUNICATIONS INC,Equity,67020Y100,14550,575000,SH,SOLE,575000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
OPTINOSE INC,Equity,68404V100,11346,1525000,SH,SOLE,1525000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,OPTN
PACIRA BIOSCIENCES INC,Equity,695127100,36729,700000,SH,SOLE,700000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,PCRX
PHREESIA INC,Equity,71944F106,11312,400000,SH,SOLE,400000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
PLEXUS CORP,Equity,729132100,4657,66000,SH,SOLE,66000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
PERRIGO CO PLC,Equity,G97822103,26253,475000,SH,SOLE,475000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,PRGO
RADNET INC,Equity,750491102,11109,700000,SH,SOLE,700000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,RDNT
RIGEL PHARMACEUTICALS INC,Equity,766559603,12536,6850000,SH,SOLE,6850000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,RIGL
SI-BONE INC,Equity,825704109,1677,105200,SH,SOLE,105200,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
SPY US 07/17/20 P290,Listed Option,78462F953,896,4000,SH,SOLE,4000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,Put,
STREAMLINE HEALTH SOLUTIONS,Equity,86323X106,5727,4305882,SH,SOLE,4305882,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,
TEVA PHARMACEUTICAL-SP ADR,Depository Receipt,881624209,3083,250000,SH,SOLE,250000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,TEVA
TEVA US 09/18/20 C10,Listed Option,881624909,1625,6500,SH,SOLE,6500,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,Call,
UNITEDHEALTH GROUP INC,Equity,91324P102,10323,35000,SH,SOLE,35000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,UNH
UNITED THERAPEUTICS CORP,Equity,91307C102,21175,175000,SH,SOLE,175000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,,UTHR
XBI US 07/17/20 P105,Listed Option,78464A950,274,2000,SH,SOLE,2000,0,0,0001661462,06-30-2020,13F-HR,false,"Tamarack Advisers, LP",07-09-2020,Put,
